Literature DB >> 16300686

Psychosocial and demographic factors associated with response to prophylactic lithium: a systematic review for bipolar disorders.

N Kleindienst1, R R Engel, W Greil.   

Abstract

BACKGROUND: The aim was to systematically integrate the available evidence on psychosocial and demographic factors associated with response prediction to prophylactic lithium.
METHOD: Each psychosocial or demographic variable that was related to lithium response in at least one study was examined with respect to response prediction. If several studies were located for the same variable results were integrated using a meta-analytical approach. To account for heterogeneity of primary studies aggregation of results was based on a random-effects model.
RESULTS: Out of 27 psychosocial and demographic variables investigated in this review, nine variables were identified as significantly related to outcome under to prophylactic lithium: (1) high social status, (2) social support, (3) good compliance, and (4) dominance may be protective against a recurrence under lithium. In contrast, (5) stress, (6) high expressed emotions, (7) neurotic personality traits, (8) unemployment, and (9) a high number of life events were identified as possible risk factors for poor response.
CONCLUSIONS: This systematic review shows a surprisingly high number of psychosocial variables to be related to lithium response. Effect sizes were, however, small to moderate. Many variables should, therefore, be considered simultaneously to predict response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300686     DOI: 10.1017/S0033291705004484

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  8 in total

1.  Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Liping Hou; Scott R Clark; Sergi Papiol; Urs Heilbronner; Franziska Degenhardt; Fasil Tekola-Ayele; Yi-Hsiang Hsu; Tatyana Shekhtman; Mazda Adli; Nirmala Akula; Kazufumi Akiyama; Raffaella Ardau; Bárbara Arias; Jean-Michel Aubry; Lena Backlund; Abesh Kumar Bhattacharjee; Frank Bellivier; Antonio Benabarre; Susanne Bengesser; Joanna M Biernacka; Armin Birner; Clara Brichant-Petitjean; Pablo Cervantes; Hsi-Chung Chen; Caterina Chillotti; Sven Cichon; Cristiana Cruceanu; Piotr M Czerski; Nina Dalkner; Alexandre Dayer; Maria Del Zompo; J Raymond DePaulo; Bruno Étain; Peter Falkai; Andreas J Forstner; Louise Frisen; Mark A Frye; Janice M Fullerton; Sébastien Gard; Julie S Garnham; Fernando S Goes; Maria Grigoroiu-Serbanescu; Paul Grof; Ryota Hashimoto; Joanna Hauser; Stefan Herms; Per Hoffmann; Andrea Hofmann; Stephane Jamain; Esther Jiménez; Jean-Pierre Kahn; Layla Kassem; Po-Hsiu Kuo; Tadafumi Kato; John Kelsoe; Sarah Kittel-Schneider; Sebastian Kliwicki; Barbara König; Ichiro Kusumi; Gonzalo Laje; Mikael Landén; Catharina Lavebratt; Marion Leboyer; Susan G Leckband; Alfonso Tortorella; Mirko Manchia; Lina Martinsson; Michael J McCarthy; Susan McElroy; Francesc Colom; Marina Mitjans; Francis M Mondimore; Palmiero Monteleone; Caroline M Nievergelt; Markus M Nöthen; Tomas Novák; Claire O'Donovan; Norio Ozaki; Urban Ösby; Andrea Pfennig; James B Potash; Andreas Reif; Eva Reininghaus; Guy A Rouleau; Janusz K Rybakowski; Martin Schalling; Peter R Schofield; Barbara W Schweizer; Giovanni Severino; Paul D Shilling; Katzutaka Shimoda; Christian Simhandl; Claire M Slaney; Alessio Squassina; Thomas Stamm; Pavla Stopkova; Mario Maj; Gustavo Turecki; Eduard Vieta; Julia Volkert; Stephanie Witt; Adam Wright; Peter P Zandi; Philip B Mitchell; Michael Bauer; Martin Alda; Marcella Rietschel; Francis J McMahon; Thomas G Schulze; Bernhard T Baune
Journal:  JAMA Psychiatry       Date:  2018-01-01       Impact factor: 21.596

2.  Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram.

Authors:  Jess G Fiedorowicz; Nancy Hale; Arthur A Spector; William H Coryell
Journal:  Ann Clin Psychiatry       Date:  2010-08       Impact factor: 1.567

Review 3.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Bernhard T Baune
Journal:  EPMA J       Date:  2017-09-05       Impact factor: 6.543

4.  Social support and social strain in inter-episode bipolar disorder.

Authors:  Polina Eidelman; Anda Gershon; Katherine Kaplan; Eleanor McGlinchey; Allison G Harvey
Journal:  Bipolar Disord       Date:  2012-08-03       Impact factor: 6.744

5.  Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder.

Authors:  Dong-Hwan Yun; Chi-Un Pae; Antonio Drago; Laura Mandelli; Diana De Ronchi; Ashwin A Patkar; In Ho Paik; Alessandro Serretti; Jung-Jin Kim
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

Review 6.  [Correct treatment of mood disorders with lithium].

Authors:  R Haussmann; U Lewitzka; E Severus; M Bauer
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

7.  GADL1 variant and medication adherence in predicting response to lithium maintenance treatment in bipolar I disorder.

Authors:  Chih-Ken Chen; Chau-Shoun Lee; Hsuan-Yu Chen; Lawrence Shih-Hsin Wu; Jung-Chen Chang; Chia-Yih Liu; Andrew Tai-Ann Cheng
Journal:  BJPsych Open       Date:  2016-09-08

Review 8.  Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.

Authors:  M Alda
Journal:  Mol Psychiatry       Date:  2015-02-17       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.